Randomised clinical trial: tegoprazan, a novel potassium‐competitive acid blocker, or lansoprazole in the treatment of gastric ulcer

BACKGROUND: Tegoprazan is a novel potassium‐competitive acid blocker for the treatment of acid‐related disorders. AIMS: To assess whether tegoprazan is non‐inferior to lansoprazole in terms of efficacy and safety in patients with gastric ulcers. METHODS: In this phase 3, double‐blind, active control...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Yu Kyung, Choi, Myung‐Gyu, Choi, Suck Chei, Lee, Kee Myung, Kim, Tae Oh, Park, Soo‐Heon, Moon, Jeong Seop, Lim, Yun Jeong, Kang, Dae Hwan, Cheon, Gab Jin, Baik, Gwang Ho, Kim, Kyoung Oh, Cho, Kwang Bum, Jang, Jin Seok, Park, Jong‐Jae, Son, Byoung Kwan, Jung, Hye‐Kyung, Kim, Byung‐Wook, Kim, Sung Kuk, Lee, Soo Teik, Cha, Jae Myung, Kim, Ah Rong, Kim, Eun Ji, Park, Hyun Wook, Song, Geun Seog
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Randomised Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496685/
https://www.ncbi.nlm.nih.gov/pubmed/32701188
http://dx.doi.org/10.1111/apt.15865

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496685/
https://www.ncbi.nlm.nih.gov/pubmed/32701188
http://dx.doi.org/10.1111/apt.15865

Ejemplares similares